NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis
Sunny Malhotra(Universitat Autònoma de Barcelona), Manuel Comabella(Universitat Autònoma de Barcelona), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Óscar Fernández(Universidad de Málaga), Begoña Oliver‐Martos(Hospital Regional Universitario de Málaga), Uwe K. Zettl(University of Rostock), Ramil Nurtdinov(Universitat Autònoma de Barcelona), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jordi Río(Universitat Autònoma de Barcelona), Jelena Drulović(University of Belgrade), Marta F. Bustamante(Universitat Autònoma de Barcelona), Filippo Martinelli Boneschi(Ollscoil na Gaillimhe – University of Galway), David Brassat(Université Toulouse III - Paul Sabatier), Antonio Garcı́a-Merino, Jeannette Lechner‐Scott(John Hunter Hospital), Elena Urcelay(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Andrew Chan(Infosys (India))
Cited by 110
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k